Rare Subtypes of Gastrointestinal Cancers
ConditionCancer of Gastrointestinal Tract
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAarhus University Hospital
A single-arm prospective observational translational study of biomarkers in patients receiving targeted treatment for rare subtypes of cancer of the Gastrointestinal Tract.
Diagnosis of a rare subtype of GI cancer including BRAF V600E mutation, MSI-H, HER2 and others
Diagnosis of cancer of the gastrointestinal tract may be made by histo- or cyto-pathology, or by clinical and imaging criteria
Planned for targeted treatment
Age 18 years or older
Conditions precluding translational blood sampling
Another concomitant cancer